Kerui Xu

1.1k total citations · 1 hit paper
17 papers, 626 citations indexed

About

Kerui Xu is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Kerui Xu has authored 17 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Kerui Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Nosocomial Infections in ICU (2 papers) and Immune Cell Function and Interaction (2 papers). Kerui Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Nosocomial Infections in ICU (2 papers) and Immune Cell Function and Interaction (2 papers). Kerui Xu collaborates with scholars based in United States, China and Canada. Kerui Xu's co-authors include Jennifer R. Verani, Matthew J. Stuckey, Meileen Acosta, Erin Epson, Shelley S. Magill, Amy Heinzerling, Kiran M. Perkins, Seema Jain, Guan Jiang and Hongmei Wang and has published in prestigious journals such as The Journal of Immunology, Preventive Medicine and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Kerui Xu

16 papers receiving 606 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020

2020 325 citations Amy Heinzerling, Matthew J. Stuckey et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Kerui Xu

PRM

ONCOL

Stephanie Tuminello United States

Françoise Renard Belgium

Lorenzo Cerruti Italy

Vincent Nguyen United Kingdom

Raman Verma United Kingdom

Thomas Byrne United Kingdom

Chi‐Jeng Hsieh Taiwan

Shell Fean Wong Hong Kong

Farheen Malik Pakistan

Theodoros Mariolis‐Sapsakos Greece

Stephanie Tuminello United States

Kerui Xu

133 ×0.7

PRM

157 ×0.8

198 ×1.1

ONCOL

105 ×0.8

90 ×0.8

Citations per year, relative to Kerui Xu Kerui Xu (= 1×) peers Stephanie Tuminello

Countries citing papers authored by Kerui Xu

Since Specialization

Citations

This map shows the geographic impact of Kerui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerui Xu more than expected).

Fields of papers citing papers by Kerui Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerui Xu. The network helps show where Kerui Xu may publish in the future.

Co-authorship network of co-authors of Kerui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kerui Xu. A scholar is included among the top collaborators of Kerui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerui Xu. Kerui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Xu, Kerui, Terrence Lee, Carolyn M. Reyes-Guzman, et al.. (2024). Use patterns of flavored non-cigarette tobacco products among US adults, 2010–2019. Preventive Medicine. 180. 107870–107870. 1 indexed citations

Liu, Shuwen, et al.. (2023). Effect of transarterial chemotherapy on the outcome and prognosis of patients with locally advanced proximal gastric cancer. PubMed Central.

Jones, Jamal, Kerui Xu, Li Deng, et al.. (2023). Smoking cessation prevalence by menthol cigarette use and select demographics among adults in the United States, TUS-CPS, 2003–2019. Preventive Medicine Reports. 36. 102440–102440. 2 indexed citations

Xu, Kerui, Hsiu Wu, Qunna Li, et al.. (2022). Association between prevalence of laboratory-identified Clostridioides difficile infection (CDI) and antibiotic treatment for CDI in US acute-care hospitals, 2019. Infection Control and Hospital Epidemiology. 43(12). 1847–1852. 1 indexed citations

Xu, Kerui, Heather Moulton-Meissner, Moon Kim, et al.. (2021). Mycobacterium chimaera infections among cardiothoracic surgery patients associated with heater-cooler devices—Kansas and California, 2019. Infection Control and Hospital Epidemiology. 43(10). 1333–1338. 9 indexed citations

Harvey, R. Reid, Randall J. Nett, R. Paul McClung, et al.. (2021). Influenza-Like Illness Among Personnel Responding to U.S. Quarantine of Cruise Ship Passengers Exposed to SARS-CoV-2. Journal of Occupational and Environmental Medicine. 64(1). 58–63. 1 indexed citations

Britton, Amadea, Kara M. Jacobs Slifka, Chris Edens, et al.. (2021). Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021. MMWR Morbidity and Mortality Weekly Report. 70(11). 396–401. 104 indexed citations

Yi, Sarah H., Isaac See, Alyssa G. Kent, et al.. (2020). Characterization of COVID-19 in Assisted Living Facilities — 39 States, October 2020. MMWR Morbidity and Mortality Weekly Report. 69(46). 1730–1735. 29 indexed citations

Heinzerling, Amy, Matthew J. Stuckey, Kerui Xu, et al.. (2020). Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020. MMWR Morbidity and Mortality Weekly Report. 69(15). 472–476. 325 indexed citations breakdown →

10.

Xu, Kerui, Liming Liu, Paraskevi A. Farazi, et al.. (2018). Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Global Health Action. 11(1). 1433987–1433987. 27 indexed citations

11.

Xu, Kerui, et al.. (2018). Common Diagnoses among Refugee Populations: Linked Results with Statewide Hospital Discharge Database. Annals of Global Health. 84(3). 541–541. 3 indexed citations

12.

Xu, Kerui, Shinobu Watanabe‐Galloway, Fedja A. Rochling, et al.. (2018). Surgical Delay Is Associated with Improved Survival in Hepatocellular Carcinoma: Results of the National Cancer Database. Journal of Gastrointestinal Surgery. 23(5). 933–943. 13 indexed citations

13.

Xu, Kerui, Shinobu Watanabe‐Galloway, Fedja A. Rochling, et al.. (2017). Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese Patients. Annals of Global Health. 83(2). 281–281. 23 indexed citations

14.

Xu, Kerui, Jing Zhao, John M. Bertoni, et al.. (2017). Comorbid Conditions in Parkinson’s Disease: A Population-Based Study of Statewide Parkinson’s Disease Registry. Neuroepidemiology. 50(1-2). 7–17. 4 indexed citations

15.

Lange, Miles D., Kerui Xu, Lin Huang, et al.. (2013). Regulation of VH Replacement by B Cell Receptor–Mediated Signaling in Human Immature B Cells. The Journal of Immunology. 190(11). 5559–5566. 10 indexed citations

16.

Wu, Tingting, Lianjun Zhang, Kerui Xu, et al.. (2012). Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo. Transplant Immunology. 27(1). 30–38. 37 indexed citations

17.

Jiang, Guan, et al.. (2012). Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis. Oncology Letters. 5(2). 417–423. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact